Hepatitis C Virus
Research from the United States and Switzerland in hepatitis C virus provides new insights
Published in Drug Week, October 20th, 2006
Study 1: A study from the United States has reported that hepatitis C virus (HCV) RNA was detected by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
"For making treatment decisions related to chronic hepatitis C, the utility of HCV RNA tests with increased sensitivity has not been defined," wrote C. Morishima and colleagues, University of Washington.
"Prior interferon nonresponders with advanced fibrosis (n=1,145) were retreated with peginterferon alpha-2a and ribavirin. Patients who were HCV...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-10-20)
More Articles from Drug Week
- Diabetes & Erectile Function
In men with type 1 diabetes, vardenafil significantly improves erectile function - Drug Development
Early study provides evidence that investigational drug phenoxodiol targets prostate cancer protein - HIV/AIDS Drug Development
Non-nucleoside inhibitors select nucleoside inhibitor resistance mutations in HIV-1 RT - Meningococcal Vaccine
Meningococcal group C vaccine elicits protective immunity within four days upon antigen challenge - Multiple Myeloma Therapy
Proteasome inhibitor drugs are under development - Accreditation
MinuteClinic receives JCAHO accreditation for retail healthcare sites - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
